Chakkumkal Anish - Concepedia

Author

Chakkumkal Anish

Max Planck Institute of Colloids and Interfaces

Also Known As

Anish, C., C. Anish, C. K. Anish, Chakkumkal Anish

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Max Planck Institute of Colloids and Interfaces Freie Universität Berlin National Institute of Immunology Max Planck Society Janssen (Netherlands)

About

Chakkumkal Anish is an author at Max Planck Institute of Colloids and Interfaces specializing in medicine, immunology, and glycobiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	709
2	Engineering	5	5	180
3	Biochemistry	5	5	235
4	Biomolecular Engineering	5	5	228
5	Natural Sciences	4	4	218

Chakkumkal Anish

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Immunological Evaluation of a Synthetic Clostridium difficile Oligosaccharide Conjugate Vaccine Candidate and Identification of a Minimal Epitope Christopher E. Martin, Felix Broecker, Matthias A. Oberli, Journal of the American Chemical Society Microbial PathogensImmunologyImmunodominanceImmunotherapeuticsInnate Immunity	2013	96
Microbe-focused glycan array screening platform Andreas Geissner, Anika Reinhardt, Christoph Rademacher, Proceedings of the National Academy of Sciences Bioorganic ChemistryGlycan Binding ProteinsGlycobiologyMolecular BiologyPolysaccharide	2019	91
A semisynthetic <i>Streptococcus pneumoniae</i> serotype 8 glycoconjugate vaccine Benjamin Schumann, Heung Sik Hahm, Sharavathi G. Parameswarappa, Science Translational Medicine	2017	83
Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines Kaustubh Jinturkar, Chakkumkal Anish, Mukesh Kumar, Biomaterials OncologyPolymer-drug ConjugateMedicineCell DeathLiposomal Formulations	2011	70
Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans Felix Broecker, Jonas Hanske, Christopher E. Martin, Nature Communications	2016	68
Synthesis, Liposomal Formulation, and Immunological Evaluation of a Minimalistic Carbohydrate-α-GalCer Vaccine Candidate Felix Broecker, Sebastian Götze, Jonathan Hudon, Journal of Medicinal Chemistry Conventional Glycoconjugate VaccineEngineeringGlycobiologyImmunologyImmunodominance	2018	63
A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection Sharavathi G. Parameswarappa, Katrin Reppe, Andreas Geissner, Cell chemical biology VaccinationVaccine DevelopmentImmunologySerotype 3Microbiology	2016	57
Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against <i>Streptococcus pneumoniae</i> Serotype 1 Benjamin Schumann, Katrin Reppe, Paulina Kapłonek, ACS Central Science	2018	50
Chemical Synthesis Elucidates the Immunological Importance of a Pyruvate Modification in the Capsular Polysaccharide of <i>Streptococcus pneumoniae</i> Serotype 4 Claney L. Pereira, Andreas Geissner, Chakkumkal Anish, Angewandte Chemie International Edition	2015	49
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine Christopher E. Martin, Felix Broecker, Steffen Eller, Chemical Communications EngineeringGlycobiologyImmunologyInfection ControlGlycosylation	2013	49

Page 1